Western Australian Consolidated Acts Western Australian Consolidated Acts The CEO is to cause a
copy of every standard referred to in this Act to be kept at the prescribed
office of the department and to be available for inspection free of charge by
members of the public at that office during normal office hours.
[Section 64B inserted by No. 48 of 1995
s. 38; amended by No. 28 of 2006 s. 282.]
All substances listed in Schedule 1 to the SUSMP.
[Schedule 1 inserted by No. 48 of 1995
s. 40; amended in Gazette 22 Oct 2010 p. 5217.]
All substances listed in Schedule 2 to the SUSMP.
[Schedule 2 inserted by No. 48 of 1995
s. 40; amended in Gazette 22 Oct 2010 p. 5217.]
All substances listed in Schedule 3 to the SUSMP.
[Schedule 3 inserted by No. 48 of 1995
s. 40; amended in Gazette 22 Oct 2010 p. 5217.]
All substances listed in Schedule 4 to the SUSMP, subject to the
following modification —
The following substance is added to Schedule 4 to the SUSMP —
* SCAEVOLA SPINESCENS.
[Schedule 4 inserted in Gazette
19 Mar 1996 p. 1208; amended in Gazette 10 Oct 2003
p. 4403 and p. 4404; 22 Oct 2010 p. 5217.]
All substances listed in Schedule 5 to the SUSMP.
[Schedule 5 inserted by No. 48 of 1995
s. 40; amended in Gazette 10 Oct 2003 p. 4404 and
p. 4405; 22 Oct 2010 p. 5217.]
All substances listed in Schedule 6 to the SUSMP, subject to the
following modification —
The following substance is deleted from Schedule 6 to the
SUSMP —
* ACETIC ANHYDRIDE excluding its derivatives.
[Schedule 6 inserted in Gazette
19 Mar 1996 p. 1208; amended in Gazette 10 Oct 2003
p. 4404 and p. 4405; 22 Oct 2010 p. 5217.]
All substances listed in Schedule 7 to the SUSMP, subject to the
following modifications —
The description of the following substance in Schedule 7 to the SUSMP is
modified in the following manner —
* In the entry for “NICOTINE”, after
the word “smoking” in paragraph (b) of that entry, insert
“or as nasal snuff”.
The following substances are added to Schedule 7 to the
SUSMP —
* ACETIC ANHYDRIDE excluding its derivatives.
*
2-ACETYL AMINOFLUORENE.
*
ALPHANAPHTHYLAMINE.
* 4-AMINOBIPHENYL.
*
BENZIDINE.
*
BENZO(A)PYRENE.
* BETANAPHTHYLAMINE.
*
BETA PROPRIOLACTONE.
*
BIS-CHLOROMETHYL ETHER.
*
3,3’-DICHLOROBENZIDINE.
*
GAMMA-BUTYROLACTONE.
* METHYL CHLOROMETHYL ETHER.
* 4-NITROBIPHENYL.
*
N-NITROSODIMETHYLAMINE.
* PHENYLACETIC ACID.
*
1-PHENYL-2-CHLOROPROPANE.
*
1-PHENYL-2-NITROPREPENE.
*
1-PHENYL-2-PROPANOL.
* 1-PHENYL-2-PROPANONE.
*
1-PHENYL-2-PROPANONE OXIME.
*
TOXAPHENE (CAMPHECHLOR).
[Schedule 7 inserted in Gazette
19 Mar 1996 p. 1208-9; amended in Gazette 14 Sep 2001
p. 5080; 22 Oct 2010 p. 5217.]
All substances listed in Schedule 8 to the SUSMP, subject to the
following modification —
The following substance is added to Schedule 8 to the SUSMP —
* 11-NOR-9-CARBOXY TETRAHYDROCANNABINOL when used
for analytical chemical analysis.
[Schedule 8 inserted by No. 48 of 1995
s. 40; amended in Gazette 8 Oct 1999 p. 4784;
22 Oct 2010 p. 5217.]
All substances listed in Schedule 9 to the SUSMP, subject to the
following modification —
The following substances are added to Schedule 9 to the
SUSMP —
* ALKOXYAMPHETAMINES AND BROMO-SUBSTITUTED
ALKOXYAMPHETAMINES except where separately specified in Schedule 9.
* ALKOXYPHENETHYLAMINES AND ALKYL-SUBSTITUTED
ALKOXYPHENETHYLAMINES except where separately specified in Schedule 9.
* BENZYLPIPERAZINE *(BZP).
* 4-BROMO-3,5-DIMETHOXYAMPHETAMINE.
* 3-BROMO-4-METHOXYAMPHETAMINE.
* 4-BROMO-3-METHOXYAMPHETAMINE.
* 1-BUTYL-3-(1-NAPHTHOYL)INDOLE *(JWH-073).
* CANNABIS OIL.
* CANNABIS RESIN.
*
1-CYCLOHEXYLETHYL-3-(2-METHOXYPHENYLACETYL)INDOLE (RCS-8).
* 3,4-DIMETHOXYAMPHETAMINE.
* 2,5-DIMETHOXY-4-ETHOXYAMPHETAMINE.
* 3,4-DIMETHOXY-5-ETHOXYAMPHETAMINE.
* 4,5-DIMETHOXY-2-ETHOXYAMPHETAMINE.
* 2,3-DIMETHOXY-4,5-METHYLENEDIOXYAMPHETAMINE.
* 2,5-DIMETHOXY-3,4-METHYLENEDIOXYAMPHETAMINE.
* 3,4-DIMETHOXYPHENYLETHYLAMINE.
* 5-(1,1-DIMETHYLHEPTYL)-2-[(1 R ,3 S )-3-
HYDROXYCYCLOHEXYL]-PHENOL *(CP 47, 497).
* 5-(1,1-DIMETHYLOCTYL)-2-[(1 R ,3 S )-3-
HYDROXYCYCLOHEXYL]-PHENOL *(CANNABICYCLOHEXANOL or CP 47, 497 C8 HOMOLOGUE).
* 4,5-ETHYLENEDIOXY-3-METHOXYAMPHETAMINE.
* 1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE
(AM-2201).
* 1-HEXYL-3-(1-NAPHTHOYL)INDOLE (JWH-019).
*
9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-6A,7,10,10A-TETRAHYDROBENZO[C]CHROMEN-1-OL
(HU-210).
* 2-METHOXY-3,4-METHYLENEDIOXYAMPHETAMINE.
* 2-METHOXY-4,5-METHYLENEDIOXYAMPHETAMINE.
* 4-METHOXY-2,3-METHYLENEDIOXYAMPHETAMINE.
* 2-METHOXY-3,4-METHYLENEDIOXYPHENYLETHYLAMINE.
* 3-METHOXY-4,5-METHYLENEDIOXYPHENYLETHYLAMINE.
* 4-METHOXYPHENYL(1-BUTYL-1H-INDOL-3-YL)-METHANONE
(RCS-4 (C4)).
*
2-(4-METHOXYPHENYL)-1-(1-PENTYL-1H-INDOL-3-YL)-ETHANONE (JWH-201).
* 2-(2-METHOXYPHENYL)-1-(1-PENTYLINDOL-3-YL)
ETHANONE *(JWH-250).
*
2-(3-METHOXYPHENYL)-1-(1-PENTYLINDOL-3-YL)ETHANONE (JWH-302).
* 4-METHOXYPHENYLETHYLAMINE.
* 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE *(MDE).
* 3,4-METHYLENEDIOXYPYROVALERONE (MDPV).
* 1-[2-(4-MORPHOLINYL)ETHYL]-3-(1-NAPHTHOYL)INDOLE
*(JWH-200).
* 1-PENTYL-3-(4-CHLORO-1-NAPHTHOYL)INDOLE
(JWH-398).
* 1-PENTYL-3-(2-CHLOROPHENYLACETYL)INDOLE
(JWH-203).
* 1-PENTYL-3-(4-ETHYL-1-NAPHTHOYL)INDOLE
(JWH-210).
* 1-PENTYL-3-[(4-METHOXY)-BENZOYL]INDOLE (RCS-4).
* 1-PENTYL-3-(4-METHOXY-1-NAPHTHOYL)INDOLE
(JWH-081).
1-PENTYL-3-(4-METHYL-1-NAPHTHOYL)INDOLE
*(JWH-122).
* 1-PENTYL-3-(1-NAPHTHOYL)INDOLE *(JWH-018).
* PRAVADOLINE (WIN 48098).
* 1-PROPYL-2-METHYL-3-(1-NAPHTHOYL)INDOLE
(JWH-015).
* 2,3,4,5-TETRAMETHOXYAMPHETAMINE.
* TRIFLUOROMETHYLPHENYLPIPERAZINE *(TFMPP).
* 2,3,4-TRIMETHOXYAMPHETAMINE.
* 2,3,6-TRIMETHOXYAMPHETAMINE.
* 2,4,5-TRIMETHOXYAMPHETAMINE.
* 2,4,6-TRIMETHOXYAMPHETAMINE.
* 2,4,5-TRIMETHOXYPHENYLETHYLAMINE.
[Schedule 9 inserted in Gazette
19 Mar 1996 p. 1209-10; amended in Gazette 8 Nov 2002
p. 5434; 22 Oct 2010 p. 5217; 17 Jun 2011
p. 2152; 5 Aug 2011 p. 3182-3; 10 Feb 2012 p. 651.]